Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Foods ; 10(2)2021 Feb 13.
Article in English | MEDLINE | ID: mdl-33668614

ABSTRACT

The effect of cooking (barbecue-grilling, boiling, microwaving, oven cooking and frying) on lipids, fatty acids (FAs) and lipid quality indices of the mussel Mytilus galloprovincialis was investigated. In general, all processing methods significantly (p < 0.05) modified the fatty acid profiles of mussels, although with major changes in fried samples, which exhibited the lowest saturated fatty acids and n-3 and highest polyunsaturated (PUFA) and n-6 FAs content. A significant decrease in the n-3 PUFA from the raw sample to five cooking methods was observed. The n-3/n-6 ratio decreased from raw (6.01) to cooked mussels, exhibiting the lowest value in fried ones (0.15). C20:5 n-3 and C22:6 n-3 significantly decreased during all cooking processes, and overall in fried mussels. It can be concluded that cooking does not compromise the nutritional quality of mussels except with frying, although it resulted in a decrease of the atherogenic and thrombogenic indices.

2.
Front Biosci (Elite Ed) ; 12(1): 183-198, 2020 03 01.
Article in English | MEDLINE | ID: mdl-32114457

ABSTRACT

Gastrointestinal (GI) health of newborns is maintained by the gastrointestinal microbiome, and the PNEI (psychoneuroendocrinoimmunology) system and can be altered by the delivery mode of the milk to the newborn such as breast versus bottle feeding, exposure to antibiotics in the milk, or exposure to environmental pollutants. The health of GI tract is particularly is maintained by breast feeding since the maternal milk provides micro- and macronutrients essential to growth, as well as multifunctional small oligosaccharides, particularly, 2'-fucosyllactose which maintain the GI health.


Subject(s)
Gastrointestinal Tract/physiology , Milk, Human/physiology , Oligosaccharides/physiology , Dietary Supplements , Gastrointestinal Microbiome , Humans , Milk, Human/chemistry , Oligosaccharides/chemistry , Oligosaccharides/therapeutic use
3.
Dermatol Ther ; 32(4): e12625, 2019 07.
Article in English | MEDLINE | ID: mdl-30156053

ABSTRACT

Vitiligo is a common disease of unknown cause that produces disfiguring white patches of depigmentation that can be treated using various new and experimental therapies, such as narrow-band ultraviolet B (NB-UVB) microphototherapy, NB-UVB excimer laser, and monochromatic excimer light. Medical treatments include topical corticosteroids and other topical treatments, such as antioxidants, tacrolimus and pimecrolimus, prostaglandin E, and vitamin D derivatives (Lotti, Berti, & Moretti, 2009). The goal of treating vitiligo is to make it less noticeable either by restoring lost pigment or by eliminating remaining pigment. Functional foods and healthy diet, with nutrients, form a variety of sources, could be considered an integral part, as well as helpful, of vitiligo's medical therapy.


Subject(s)
Vitiligo/diet therapy , Curcumin/therapeutic use , Dietary Supplements , Food, Fortified , Ginkgo biloba , Humans , Khellin/therapeutic use , Oxidative Stress , Polypodium , Reactive Oxygen Species/metabolism , Tea , Vitiligo/immunology , Vitiligo/metabolism
4.
Dermatol Ther ; 32(1): e12746, 2019 01.
Article in English | MEDLINE | ID: mdl-30238567

ABSTRACT

Many skin disorders have been associated with nutritional deficiencies, as well as many skin disorders, have been associated to diet-related immune mechanisms. The food can be a source of beneficial substances for health that act in very precise ways on the body and the functioning of each individual cells, tissues, and organs.


Subject(s)
Delivery of Health Care, Integrated/methods , Dermatology/methods , Diet, Healthy , Nutrition Therapy/methods , Skin Diseases/diet therapy , Humans , Nutritional Status , Nutritive Value , Recommended Dietary Allowances , Skin Diseases/immunology , Skin Diseases/physiopathology
5.
Open Access Maced J Med Sci ; 6(10): 1875-1877, 2018 Oct 25.
Article in English | MEDLINE | ID: mdl-30455766

ABSTRACT

BACKGROUND: Lipomas are benign formations with the mesenchymal origin, which are found in the head and neck region in a very small percentage of cases. In these cases, they usually occur in the posterior neck and usually grow very slowly without causing complaints. However, when they cover the front of the neck, it is necessary to confirm the adipose origin of a tumour and to exclude the connection with the thyroid gland. Although in principle, lipomas are benign, there are three more unfavourable possibilities of 1) malignancy of lipomas, 2) the occurrence of de novo liposarcomas or 3) the association of lipomas with other tumours, such as retinoblastoma. CASE REPORT: We present a 74-year-old woman with a painless subcutaneous formation in the neck. A Fine Needle Aspiration Biopsy (FNA) was performed, with the conclusion of the cytological result for lipoma. Surgical removal was planned under general anaesthesia. CONCLUSION: Usually, lipomas do not require surgery, but when they engage muscles they become indicative of surgical treatment.

6.
Dermatol Ther ; 31(6): e12678, 2018 11.
Article in English | MEDLINE | ID: mdl-30411455

ABSTRACT

Vulvovaginal atrophy is a condition that affects women, although it is mainly associated with the onset of menopause mainly due to hormonal changes vulvovaginal laxity and mucosal atrophy can also affect women at different life stages such as after pregnancy or for cancer patients who have undergone chemo or endocrine therapy. This condition negatively influence quality of life, sexual desire, and self-confidence. Many therapies have been considered mainly with inconclusive or transient results in terms of benefit factor. Recently, a new non-invasive product, containing hyaluronic acid, oligopeptides, and antioxidants was introduced to the market. Its name is "Primavera," by Renaissance, Italy. The aim of this product is to allow a vulvo-vaginal biostimulation and considered simple, safe, and satisfactory.


Subject(s)
Rejuvenation , Vagina/drug effects , Vaginal Diseases/drug therapy , Vulva/drug effects , Vulvar Diseases/drug therapy , Antioxidants/adverse effects , Antioxidants/therapeutic use , Atrophy , Female , Humans , Oligopeptides/adverse effects , Oligopeptides/therapeutic use , Recovery of Function , Treatment Outcome , Vagina/pathology , Vagina/physiopathology , Vaginal Diseases/pathology , Vaginal Diseases/physiopathology , Vulva/pathology , Vulva/physiopathology , Vulvar Diseases/pathology , Vulvar Diseases/physiopathology
7.
Monaldi Arch Chest Dis ; 87(2): 840, 2017 07 18.
Article in English | MEDLINE | ID: mdl-28967718

ABSTRACT

In the last 25 years, the number of patients aged ≥75 years undergoing non-cardiac surgery has greatly increased. In elderly patients, frailty is significantly associated with an increased risk of adverse events, functional decline, procedural complications, prolonged hospitalization, and mortality. The relationship between frailty and increased mortality and morbidity requires an appropriate tool of assessment to accurately quantify the patient's clinical and perioperative conditions. The preoperative evaluation of elderly patients candidate for non-cardiac surgery should include assessment of frailty, sarcopenia and malnutrition, as these are related to high surgical risk. For colon-rectal surgery as also for gastric cancer surgery, especially early gastric cancer, the introduction of laparoscopy has yielded considerable benefits in terms of short-term postsurgical outcomes, e.g. lower rate of intraprocedural bleeding and reduced length of hospital stay. Despite the progress made in preoperative assessment, surgical procedures and postoperative management, the improvement of outcomes after non-cardiac surgery in elderly patients remains a challenge and calls for future, well-designed clinical studies.


Subject(s)
Frailty/mortality , Postoperative Care/standards , Postoperative Complications/mortality , Preoperative Care/standards , Aged , Aged, 80 and over , Colorectal Surgery/adverse effects , Colorectal Surgery/mortality , Humans , Laparoscopy/statistics & numerical data , Length of Stay , Malnutrition/epidemiology , Morbidity , Mortality , Patient Outcome Assessment , Patient Readmission/statistics & numerical data , Risk Assessment , Risk Factors , Sarcopenia/diagnosis , Sarcopenia/epidemiology , Stomach Neoplasms/complications , Stomach Neoplasms/mortality , Stomach Neoplasms/surgery
8.
Monaldi Arch Chest Dis ; 87(2): 844, 2017 07 18.
Article in English | MEDLINE | ID: mdl-28967728

ABSTRACT

Advanced age is a strong predictor of high perioperative mortality in surgical patients and patients aged 75 years and older have an elevated surgical risk, much higher than that of younger patients. Progressive advances in surgical techniques now make it possible to treat high-risk surgical patients with minimally invasive procedures. Endovascular techniques have revolutionized the treatment of several vascular diseases, in particular carotid stenosis, aortic pathologies, and severely incapacitating intermittent claudication or critical limb ischemia. The main advantages of the endovascular approach are the low complication rate, high rate of technical success and a good clinical outcome. Biliary stenting has improved the clinical status of severely ill patients with bile duct stricture before major surgery, and represents a good palliative therapy in the case of malignant biliary obstruction.


Subject(s)
Minimally Invasive Surgical Procedures/adverse effects , Perioperative Period/mortality , Surgical Procedures, Operative/adverse effects , Vascular Diseases/surgery , Aged , Aged, 80 and over , Biliary Tract Diseases/epidemiology , Biliary Tract Diseases/surgery , Endovascular Procedures/methods , Humans , Minimally Invasive Surgical Procedures/methods , Palliative Care , Risk Reduction Behavior , Stents , Surgical Procedures, Operative/methods , Treatment Outcome , Vascular Diseases/epidemiology
9.
Open Med (Wars) ; 12: 50-57, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28435905

ABSTRACT

We present an original case report of a bladder explosion during a TURP intervention for benign prostatic hypertrophy, that was brought on by the absorption of about 5 liters of glycine 1.5% and then onset of a severe hyponatremia. The quick and inappropriate correction of this electrolyte imbalance led the onset of encephalopathy and the death of the patient. The authors discuss the pathogenesis of these uncommon diseases and, considering the most recent Italian Legislation, they highlight the importance to respect good clinical practice standards and guidelines to ensure the most appropriate treatments for the patient and remove any assumptions of medical liability.

11.
Minerva Cardioangiol ; 64(1): 34-40, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26989948

ABSTRACT

BACKGROUND: The purpose of the study was to evaluate the effectiveness of the treatment with one tablet a day of a low dose multicomponent medication (Arnica comp.-Heel® tablets) with anti-inflammatory properties in order to reduce the risk of cardiovascular events in patients with clinically stable coronary disease. The presence of inflammatory cells in atherosclerotic plaques of patients with stable coronary disease indicates the possibility to act by inhibiting the inflammatory phenomenon with Arnica comp.-Heel® tablets reducing the risk of instability of the plaque and, consequently, improving the clinical outcome in patients with stable coronary disease. METHODS: Within this retrospective observational spontaneous clinical study 44 patients (31 males and 13 females) all presenting stable coronary artery disease were evaluated; 25 subjects were treated with only acetylsalicylic acid and/or clopidogrel in association with statins (standard therapeutic protocol) while for the other 18 subjects the standard therapeutic protocol was integrated with Arnica comp.-Heel® (one sublingual tablet/day). The primary outcome was to evaluate the incidence of acute coronary syndrome, out-of-hospital cardiac arrest, or non-cardioembolic ischemic stroke. RESULTS: The evaluation of the primary outcome showed that in the group of patients (18) who received the standard therapeutic protocol plus Arnica comp.-Heel® only one cardiovascular event was registered (5.6%) while in the group treated only with standard therapy 4 events were recorded in 25 patients (16%). CONCLUSIONS: The treatment with Arnica comp.-Heel® (one tablet/day) in combination with standard therapies for secondary prevention is effective in reducing the incidence of cardiovascular events in patients with stable coronary artery disease.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Coronary Artery Disease/drug therapy , Inflammation/drug therapy , Plants, Medicinal/chemistry , Aged , Aged, 80 and over , Anti-Inflammatory Agents/isolation & purification , Aspirin/administration & dosage , Aspirin/therapeutic use , Clopidogrel , Coronary Artery Disease/pathology , Drug Therapy, Combination , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Inflammation/pathology , Male , Middle Aged , Plaque, Atherosclerotic/drug therapy , Plaque, Atherosclerotic/pathology , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/therapeutic use , Retrospective Studies , Secondary Prevention/methods , Tablets , Ticlopidine/administration & dosage , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...